Winton Group’s Medicines Co MDCO Stock Holding History

Winton Group’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-23,489	Closed	-$2M	–	1626
2019 Q4	$2M	Buy	+23,489	New	+$1.57M	0.03%	804

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Winton Group's MDCO Position: Q1 2020 in Review

Winton Group sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 23,489 shares — an estimated $2M sold.

Winton Group first reported a position in MDCO in Q4 2019 and held it in 1 quarter. The position peaked at $2M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Winton Group reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Winton Group sold 23,489 Medicines Co shares in Q1 2020, an estimated $2M.
Winton Group first reported a position in Medicines Co in Q4 2019 and held it in 1 quarter.
Winton Group's Medicines Co position peaked at $2M in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Winton Group's 13F filing for Q1 2020, filed 11 May 2020.